Silicon
Star0
This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Explore a selection of our essential drug information below, or:
Identification
- Summary
Silicon is a micronutrient indicated in nutritional products to treat or prevent silicon deficiencies.
- Generic Name
- Silicon
- DrugBank Accession Number
- DB12982
- Background
Silicon is under investigation in clinical trial NCT00103246 (Photodynamic Therapy Using Silicon Phthalocyanine 4 in Treating Patients With Actinic Keratosis, Bowen's Disease, Skin Cancer, or Stage I or Stage II Mycosis Fungoides).
- Type
- Small Molecule
- Groups
- Approved, Investigational
- Structure
- Weight
- Average: 28.085
Monoisotopic: 27.976926535 - Chemical Formula
- Si
- Synonyms
- silicio
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Therapies
- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Take with food.
Products
- Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.
- Over the Counter Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image FMD FloraSilica Capsule Capsule 4.7 mg Oral BASIC HEALTH & BEAUTY SDN BHD 2020-09-08 Not applicable Malaysia - Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Actical Plus Calcium-magnesium-vitamin D3-silicon Chewable Silicon (2 mg) + Calcium (200 mg) + Cholecalciferol (100 unit) + Magnesium (100 mg) Tablet Oral Usana Health Sciences, Inc. 1999-09-30 2004-07-27 Canada Active Calcium Plus Magnesium, Vitamin D and Silicon Silicon (2.25 mg) + Calcium (200 mg) + Cholecalciferol (100 unit) + Magnesium (100 mg) Tablet Oral Usana Health Sciences, Inc. 2002-07-08 2007-07-18 Canada Advanced B & T Formula Silicon (0.333 mg) + Ascorbic acid (33.3 mg) + Calcium (200 mg) + Chromium (33.33 mcg) + Copper (0.5 mg) + Cyanocobalamin (6.67 mcg) + Folic acid (0.133 mg) + Iron (1.67 mg) + Magnesium (83.3 mg) + Manganese cation (3.33 mg) + Nicotinamide (6.67 mg) + Calcium pantothenate (5 mg) + Phosphorus (100 mg) + Potassium (16.67 mg) + Pyridoxine hydrochloride (6.67 mg) + Riboflavin (2.67 mg) + Selenium (33.33 mcg) + Sodium molybdate (16.67 mcg) + Thiamine (2.67 mg) + Vanadium (8.33 mg) + Vitamin D (66.67 unit) + Zinc (5 mg) Capsule Oral Nutraceutical Corporation Not applicable Not applicable Canada BIOGROW MIN Silicon (12.5 mcg) + Boron (500 mcg) + Calcium (15 mg) + Chromium (16.8 mcg) + Copper (100 mcg) + Iodine (33.5 mcg) + Iron (3 mg) + Lithium carbonate (117 mcg) + Magnesium (5 mg) + Manganese cation (700 mcg) + Molybdenum (12.6 mcg) + Nickel cation (67 mcg) + Phosphorus (2 mg) + Potassium (5 mg) + Selenium (16.7 mcg) + Vanadium (8.5 mcg) + Zinc (2 mg) Tablet, film coated Oral UNISON NUTRACEUTICALS SDN. BHD. 2020-09-08 Not applicable Malaysia BIOGROW® VITE Silicon (9 mcg) + Ascorbic acid (25 mg) + Beta carotene (500 IU) + Biotin (50 mcg) + Boron (50 mcg) + Bromelains (12.5 mg) + Calcium (2.25 mg) + Cholecalciferol (200 IU) + Choline (8.5 mg) + Chromium (10 mcg) + Copper (34 mcg) + Cyanocobalamin (2 mcg) + Folic acid (125 mcg) + Inositol (1.75 mg) + Iodine (56 mcg) + Iron (2 mg) + Magnesium (1.5 mg) + Manganese cation (750 mcg) + Molybdenum (9 mcg) + Nicotinamide (10 mg) + Pancrelipase amylase (12.5 mg) + Pantothenic acid (10 mg) + Papain (12.5 mg) + Phosphorus (2.5 mg) + Potassium (2.5 mg) + Pyridoxine (5 mg) + Riboflavin (2 mg) + Selenium (17 mcg) + Thiamine (2 mg) + Thiamine (2.5 mg) + Vanadium (4 mcg) + Vitamin A (2500 IU) + Vitamin E (15 IU) + Zinc (2 mg) Tablet Oral UNISON NUTRACEUTICALS SDN. BHD. 2020-09-08 Not applicable Malaysia
Categories
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of inorganic compounds known as homogeneous metalloid compounds. These are inorganic compounds containing only metal atoms,with the largest atom being a metalloid atom.
- Kingdom
- Inorganic compounds
- Super Class
- Homogeneous metal compounds
- Class
- Homogeneous metalloid compounds
- Sub Class
- Not Available
- Direct Parent
- Homogeneous metalloid compounds
- Alternative Parents
- Not Available
- Substituents
- Homogeneous metalloid
- Molecular Framework
- Not Available
- External Descriptors
- nonmetal atom, carbon group element atom (CHEBI:27573)
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- Z4152N8IUI
- CAS number
- 7440-21-3
- InChI Key
- XUIMIQQOPSSXEZ-UHFFFAOYSA-N
- InChI
- InChI=1S/Si
- IUPAC Name
- silicon
- SMILES
- [Si]
References
- General References
- Not Available
- External Links
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample data
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Tablet, film coated Oral Capsule Oral Tablet Oral Capsule Oral 4.7 mg Solution / drops Oral 6.66 % Emulsion Oral 80 MG/ML Tablet, chewable Oral 120 MG Tablet, chewable Oral 40 MG Tablet, chewable Oral 80 MG - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source logP 0.045 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 0 Chemaxon Hydrogen Donor Count 0 Chemaxon Polar Surface Area 0 Å2 Chemaxon Rotatable Bond Count 0 Chemaxon Refractivity 0 m3·mol-1 Chemaxon Polarizability 1.78 Å3 Chemaxon Number of Rings 0 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule Yes Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at October 21, 2016 01:46 / Updated at July 26, 2024 01:51